First author | Year | Country | Study design | Ethnicity | Sample size | Source of controls | Genotyping method | Age (mean) | Knee OA definition | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
 |  |  |  |  | Case | Control |  |  | Case | Control | Radiographic* | Clinical†| TKR |
Southama | 2007 | UK | Case–control | Caucasian | 349 | 822 | HB | PCR-RFLP | 65 | 69 |  |  | + |
Southamb | 2007 | Spain | Case–control | Caucasian | 274 | 1196 | HB | TaqMan | NA | >55.0 |  |  | + |
Miyamotoa | 2007 | Japan | Case–control | Asian | 718 | 861 | HB | TaqMan, Invader, DNA fragment analysis or Direct sequence | 71.9 | 49.4 | + |  |  |
Miyamotob | 2007 | China | Case–control | Asian | 313 | 485 | HB | TaqMan, Invader, DNA fragment analysis or Direct sequence | 58.8 | 56.8 | + |  |  |
Tsezou | 2007 | Greece | Case–control | Caucasian | 251 | 268 | HB | Direct sequence | 67.9 | 65.2 | + |  |  |
Chapman | 2008 | Netherlands | Cohort study | Caucasian | 142 | 724 | PB | Mass spectrometry | 60.4 | 59.6 | + | Â | Â |
Valdesa | 2009 | UK | Case–control | Caucasian | 735 | 654 | HB | Allele-specific PCR | 68.5 | 66.9 |  | + |  |
Valdesb | 2009 | UK | Cohort study | Caucasian | 264 | 512 | PB | Allele-specific PCR | 66.3 | 63 | + | Â | Â |
Vaes | 2009 | Netherlands | Cohort study | Caucasian | 667 | 2097 | PB | TaqMan | >55.0 | >55.0 | + | Â | Â |
Evangeloua | 2009 | Iceland | Cohort study | Caucasian | 1071 | 1169 | PB | Centaurus platform | 74.8 | 74.8 | Â | Â | + |
Evangeloub | 2009 | UK | Twins study | Caucasian | 177 | 548 | NA | Illumina platform | 54.3 | 54.3 | + | Â | Â |
Evangelouc | 2009 | Finland | Family-based study | Caucasian | 109 | 209 | NA | Mass spectrometry | 67 | 58 | + | Â | + |
Cao | 2010 | Korea | Case–control | Asian | 276 | 298 | PB | PCR-RFLP | 63 | 44 |  |  | + |
Tawonsawatruk | 2011 | Thailand | Case–control | Asian | 103 | 103 | HB | PCR-RFLP | 68.5 | 59.25 |  |  | + |
Valdea | 2011 | UK | Cohort study | Caucasian | 867 | 758 | PB | Allele-specific PCR | 66.5 | 66.5 | Â | Â | + |
Valdesb | 2011 | Estonian | Cohort study | Caucasian | 65 | 427 | PB | Allele-specific PCR | 47.1 | 47.1 | + | Â | Â |
Valdesc | 2011 | UK | Cohort study | Caucasian | 1141 | 536 | PB | Allele-specific PCR | 65.5 | 65.5 | + | Â | + |
Valdesd | 2011 | Netherlands | Cohort study | Caucasian | 162 | 1582 | PB | TaqMan | >45.0 | >45.0 | + | Â | Â |
Shin | 2012 | Korea | Cohort study | Asian | 725 | 1737 | PB | High resolution melting analysis | 67.4 | 62.7 | + | Â | Â |
Mhishra | 2013 | India | Case–control | Asian | 300 | 300 | HB | PCR-RFLP | 54.0 | 55.2 | + | + |  |